S content for intestinal milieu disorder treatment. The presented study therefore opens the door for further exploitation for IBDs therapy.
No takes yet. Share an insight, caveat, or question.
Dou et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: